Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:IMMU

Immunomedics (IMMU) Stock Price, News & Analysis

Immunomedics logo

About Immunomedics Stock (NASDAQ:IMMU)

Advanced Chart

Key Stats

Today's Range
$87.86
$87.86
50-Day Range
$85.08
$87.86
52-Week Range
$8.80
$87.93
Volume
N/A
Average Volume
4.01 million shs
Market Capitalization
$20.31 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMMU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Immunomedics and its competitors with MarketBeat's FREE daily newsletter.

IMMU Stock News Headlines

Gilead Sciences Tops Estimates in Q3
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Gilead Sciences Shows Strong Q3 Results Amid Strategic Initiatives
See More Headlines

IMMU Stock Analysis - Frequently Asked Questions

Immunomedics, Inc. (NASDAQ:IMMU) issued its quarterly earnings data on Wednesday, August, 5th. The biopharmaceutical company reported ($0.73) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.39. The biopharmaceutical company had revenue of $20.07 million for the quarter, compared to analysts' expectations of $24.81 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Immunomedics investors own include Bristol Myers Squibb (BMY), NVIDIA (NVDA), Seagen (SGEN), Synergy Pharmaceuticals (SGYP), Micron Technology (MU), Gilead Sciences (GILD) and Meta Platforms (META).

Company Calendar

Last Earnings
8/05/2020
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:IMMU
CIK
722830
Fax
N/A
Employees
366
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.84)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$357.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-132.40%
Return on Assets
-51.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.84
Quick Ratio
12.58

Sales & Book Value

Annual Sales
$290 thousand
Price / Sales
70,028.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.38 per share
Price / Book
63.67

Miscellaneous

Outstanding Shares
231,144,000
Free Float
N/A
Market Cap
$20.31 billion
Optionable
Optionable
Beta
2.90
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:IMMU) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners